CABERGOLINE

Clinical Indication

Hyperprolactinaemic disorders

Comments

Annual monitoring undertaken in secondary care Primary care should be aware of fibrotic reactions

Date of classification

May 2019

Yellow

Medicines initiated or recommended by a specialist service for prescribing in primary care which do not require initiation or ongoing oversight by the specialist. There are no specific paperwork requirements between provider organisations and a verbal request may be acceptable through advice and guidance as long enough information is provided so that the transfer of care is safe.